Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M
Venture Capital

Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M

by xconomy.com posted 1year ago 385 views
Grail said today that it has raised more than $900 million in a Series B round led by Arch Venture Partners. Johnson & Johnson Innovation made the largest investment of any involved in the massive financing, Grail said in a statement, but it was also helped by three other drugmakers (Bristol-Myers Squibb, Celgene, Merck), tech giant Amazon, the venture arm of healthcare services firm McKesson, China-based Tencent Holdings, and Varian Medical Systems, a developer of radiation cancer treatments.